CVTX received their FDA approval and line extentions for Ranexa and was PR'd early this AM.  This is good news for patients with angina and allows CVTX to sell this on expanded levels and therfore increase its profit!

 

 

Been a long haul for this ticker since Greedy presented it almost 16 months ago and Cramer was pumping it.  Kutz has been holding onto shares throughout. 

 

I watch what this PPS will do on this great news and yet still within the noise of a bad market overall.  Therefore who knows how it will react?

 

Some say this company will get bought out with the news today?  My time with this ticker is about done no matter where the momentum goes here.  Depending on what happens, its almost time to move my money to another entity.

 

Kutz